Clinical Trails (Leqembi/Lecanemab)
The Alzheimer’s Association celebrated on July 6, 2023 to the FDA’s action of approving Leqembi for treatment of early Alzheimer’s for people who showed elevation of amyloid beta. Dr. Joanne Pike, President Of The Alzheimer’s Association, said,” Even though this is not is cure it will give people in the early stages to maintain their…